MedTrace Logo

Comparison of Individuals With Primary Ciliary Dyskinesia and Healthy Controls

NCT07740551 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2026-07-31

No results posted yet for this study

Summary

To date, the literature has not yet elucidated the status of malnutrition and sarcopenia in children and adolescents with PCD compared to healthy controls. Therefore, the aim of this study is to compare the nutritional and sarcopenia status of children and adolescents with primary ciliary dyskinesia to that of healthy controls.

Conditions

  • Primary Ciliary Dyskinesia (PCD)

Interventions

OTHER

Physical Evaluations in Children with Primary Ciliary Dyskinesia

In this study, malnutrition and sarcopenia status in children and adolescents diagnosed with primary ciliary dyskinesia will be evaluated. All data pertaining to these assessments will be acquired via face-to-face interviews with a duration of 45 to 60 minutes.

OTHER

Physical Evaluations in Healthy Children

In this study, malnutrition and sarcopenia status in children and adolescents diagnosed with primary ciliary dyskinesia will be evaluated. All data pertaining to these assessments will be acquired via face-to-face interviews with a duration of 45 to 60 minutes.

Sponsors & Collaborators

  • Izmir Democracy University

    lead OTHER

Principal Investigators

  • Gülşah Barğı, Assoc Prof · Izmir Democracy University

  • Aybüke S Demir, PT, MSc · Izmir Democracy University

  • Kerim K Göküstün, Asst Prof · Izmir Democracy University

  • Ece Ocak, Dr · Izmir City Hospital

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-01
Primary Completion
2027-08-01
Completion
2027-08-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07740551 on ClinicalTrials.gov